SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

54.96

15628.61

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.51

Back

&hra pradesh state financial corpn ltd

Innovassynth Technologies (India) reports standalone net profit of Rs 6.74 crore in the June 2026 quarter

Aug 13,2026

Net profit of Innovassynth Technologies (India) reported to Rs 6.74 crore in the quarter ended June 2026 as against net loss of Rs 18.67 crore during the previous quarter ended June 2025. Sales rose 356.32% to Rs 55.99 crore in the quarter ended June 2026 as against Rs 12.27 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	55.99	12.27	356
OPM %	26.74	-126.65	-
PBDT	13.16	-16.80	LP
PBT	11.16	-18.75	LP
NP	6.74	-18.67	LP

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)